vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Safehold Inc. (SAFE). Click either name above to swap in a different company.

Safehold Inc. is the larger business by last-quarter revenue ($97.9M vs $83.1M, roughly 1.2× PROCEPT BioRobotics Corp). Safehold Inc. runs the higher net margin — 28.5% vs -38.1%, a 66.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 6.5%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 2.5%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

SAFE Investment Company Limited is a Chinese sovereign wealth fund based in Hong Kong.

PRCT vs SAFE — Head-to-Head

Bigger by revenue
SAFE
SAFE
1.2× larger
SAFE
$97.9M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+13.7% gap
PRCT
20.2%
6.5%
SAFE
Higher net margin
SAFE
SAFE
66.5% more per $
SAFE
28.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
2.5%
SAFE

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
SAFE
SAFE
Revenue
$83.1M
$97.9M
Net Profit
$-31.6M
$27.9M
Gross Margin
64.9%
98.6%
Operating Margin
-4.1%
27.4%
Net Margin
-38.1%
28.5%
Revenue YoY
20.2%
6.5%
Net Profit YoY
-27.9%
7.1%
EPS (diluted)
$-0.56
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SAFE
SAFE
Q1 26
$83.1M
Q4 25
$76.4M
$97.9M
Q3 25
$83.3M
$96.2M
Q2 25
$79.2M
$93.8M
Q1 25
$69.2M
$97.7M
Q4 24
$68.2M
$91.9M
Q3 24
$58.4M
$90.7M
Q2 24
$53.4M
$89.9M
Net Profit
PRCT
PRCT
SAFE
SAFE
Q1 26
$-31.6M
Q4 25
$-29.8M
$27.9M
Q3 25
$-21.4M
$29.3M
Q2 25
$-19.6M
$27.9M
Q1 25
$-24.7M
$29.4M
Q4 24
$-18.9M
$26.0M
Q3 24
$-21.0M
$19.3M
Q2 24
$-25.6M
$29.7M
Gross Margin
PRCT
PRCT
SAFE
SAFE
Q1 26
64.9%
Q4 25
60.6%
98.6%
Q3 25
64.8%
98.5%
Q2 25
65.4%
99.1%
Q1 25
63.9%
98.8%
Q4 24
64.0%
98.8%
Q3 24
63.2%
98.8%
Q2 24
59.0%
98.8%
Operating Margin
PRCT
PRCT
SAFE
SAFE
Q1 26
-4.1%
Q4 25
-40.6%
27.4%
Q3 25
-27.8%
25.9%
Q2 25
-28.0%
25.5%
Q1 25
-39.7%
25.9%
Q4 24
-28.9%
24.6%
Q3 24
-38.4%
17.5%
Q2 24
-50.3%
26.7%
Net Margin
PRCT
PRCT
SAFE
SAFE
Q1 26
-38.1%
Q4 25
-39.1%
28.5%
Q3 25
-25.7%
30.5%
Q2 25
-24.7%
29.8%
Q1 25
-35.8%
30.1%
Q4 24
-27.6%
28.3%
Q3 24
-35.9%
21.3%
Q2 24
-48.0%
33.0%
EPS (diluted)
PRCT
PRCT
SAFE
SAFE
Q1 26
$-0.56
Q4 25
$-0.54
$0.38
Q3 25
$-0.38
$0.41
Q2 25
$-0.35
$0.39
Q1 25
$-0.45
$0.41
Q4 24
$-0.34
$0.36
Q3 24
$-0.40
$0.27
Q2 24
$-0.50
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SAFE
SAFE
Cash + ST InvestmentsLiquidity on hand
$245.6M
$21.7M
Total DebtLower is stronger
$51.7M
$4.6B
Stockholders' EquityBook value
$347.7M
$2.4B
Total Assets
$487.1M
$7.2B
Debt / EquityLower = less leverage
0.15×
1.90×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SAFE
SAFE
Q1 26
$245.6M
Q4 25
$286.5M
$21.7M
Q3 25
$294.3M
$12.1M
Q2 25
$302.7M
$13.9M
Q1 25
$316.2M
$17.3M
Q4 24
$333.7M
$8.3M
Q3 24
$196.8M
$15.6M
Q2 24
$214.1M
$13.4M
Total Debt
PRCT
PRCT
SAFE
SAFE
Q1 26
$51.7M
Q4 25
$51.6M
$4.6B
Q3 25
$51.6M
$4.5B
Q2 25
$51.5M
$4.4B
Q1 25
$51.5M
$4.3B
Q4 24
$51.5M
$4.3B
Q3 24
$51.4M
$4.3B
Q2 24
$51.4M
$4.2B
Stockholders' Equity
PRCT
PRCT
SAFE
SAFE
Q1 26
$347.7M
Q4 25
$365.9M
$2.4B
Q3 25
$380.3M
$2.4B
Q2 25
$385.8M
$2.4B
Q1 25
$389.2M
$2.4B
Q4 24
$402.2M
$2.3B
Q3 24
$241.2M
$2.3B
Q2 24
$251.8M
$2.3B
Total Assets
PRCT
PRCT
SAFE
SAFE
Q1 26
$487.1M
Q4 25
$508.1M
$7.2B
Q3 25
$511.5M
$7.1B
Q2 25
$513.1M
$7.1B
Q1 25
$519.4M
$6.9B
Q4 24
$534.0M
$6.9B
Q3 24
$374.1M
$6.8B
Q2 24
$374.4M
$6.8B
Debt / Equity
PRCT
PRCT
SAFE
SAFE
Q1 26
0.15×
Q4 25
0.14×
1.90×
Q3 25
0.14×
1.89×
Q2 25
0.13×
1.87×
Q1 25
0.13×
1.85×
Q4 24
0.13×
1.84×
Q3 24
0.21×
1.88×
Q2 24
0.20×
1.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SAFE
SAFE
Operating Cash FlowLast quarter
$47.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SAFE
SAFE
Q1 26
Q4 25
$-10.3M
$47.8M
Q3 25
$-6.6M
$-1.4M
Q2 25
$-15.0M
$28.0M
Q1 25
$-17.0M
$8.9M
Q4 24
$-32.4M
$37.9M
Q3 24
$-18.8M
$8.3M
Q2 24
$-15.7M
$24.8M
Free Cash Flow
PRCT
PRCT
SAFE
SAFE
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
PRCT
PRCT
SAFE
SAFE
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
PRCT
PRCT
SAFE
SAFE
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
PRCT
PRCT
SAFE
SAFE
Q1 26
Q4 25
1.72×
Q3 25
-0.05×
Q2 25
1.00×
Q1 25
0.30×
Q4 24
1.45×
Q3 24
0.43×
Q2 24
0.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SAFE
SAFE

Equity Method Investment Nonconsolidated Investee Or Group Of Investees$60.3M62%
Other$33.7M34%
Stabilized Properties$3.8M4%

Related Comparisons